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Introduction
Prostate cancer continues to be the most significant cancer
proven to disproportionately overburden men of African
descent, especially United States (US) Black men. Unfortu-
nately, African American race/ethnicity is one of the three
primary non-modifiable risk factors confirmed for prostate
cancer.
1,2 We are yet to confirm the primary reasons for
the disparate burden of prostate cancer among Black men.
This problem is further compounded by the fact that pros-
tate cancer has become a major public health problem in
developing countries. Thereby, global collaborations
among prostate cancer scientists, clinicians, survivors and
advocates are important to better understand the etiology
of prostate cancer among at-risk Black men, and develop
effective interventions to address these disparities.
The Science of Global Prostate Cancer Disparities
in Black Men conference was organized to:
1. Provide opportunities for mutual learning, knowledge
transfer, and collaborations among prostate cancer scien-
tist clinicians, survivors and advocates.
2. Promote trans-disciplinary and multi-disciplinary
prostate cancer research globally;
3. Facilitate networking among individuals involved in
all aspects of prostate cancer control, education and
research in Black men.
4. Facilitate the development of a global community of
practice to address common challenges in prostate cancer,
including prevention, detection, diagnosis, treatment and
survivorship.
5. Contribute to a global impact against prostate cancer
through research training and education programs for
low-resource countries.
The primary goals for participants were to:
￿ Learn - Learn from internationally renowned speakers
recognized in prostate cancer disparities and survivorship
research.
￿ Discover - Discover the latest research findings on
prostate cancer Prevention, Early Detection, Diagnosis,
Treatment, Survivorship and End-of-Life.
￿ Connect - Connect with other Researchers, Clini-
cians, Patients, Advocates and Policy makers from North
America, South America, Europe, Africa, and the
Caribbean.
￿ Share - Share ideas with other conference delegates
involved in all aspects of prostate cancer control and
research in Black Men.
￿ Explore - Explore the world of trans-disciplinary
prostate cancer research.
￿ Develop - Develop a global community of practice to
address common challenges in prostate cancer
disparities.
The 1
st Biennial Science of Global Prostate Cancer Dis-
parities in Black Men Conference was held in the heart
of downtown Jacksonville, Florida on August 27-29,
2010. A total of 96 delegates participated in the confer-
ence, including 21 patient/survivors, family, and friends.
There were 15 international delegates from Africa, the
Caribbean, and United Kingdom.
Pre-conference workshops
There were a total of six pre-conference workshops, with
three concurrent sessions in the morning and three con-
current sessions in the afternoon. Dr. Philipp Dahm
chaired the first workshop. Dr. Dahm and Dr. Isaac
Powell, presented the latest findings on Prostate Cancer
Treatment & Outcomes. The second workshop was
chaired by Dr. Durado Brooks. Dr. Brooks and Dr. Kevin
Stein discussed Prostate Cancer Prevention, Early Detec-
tion, and Survivorship. Dr. Brian Cleaver chaired the
third workshop and discussed Research Ethics: Protection
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attended by international delegates. The afternoon concur-
rent workshops were chaired by Dr. Diane Woods,
Dr. R. Renee Reams and Dr. Titilola Akinremi (Nigeria).
The session chaired by Dr. Woods focused on Tools for
Low Resource Countries. She presented Community-
based Participatory Research and Ms. Tara Hylton dis-
cussed Cancer Registration. For the fifth workshop,
Dr. Reams (chair), Dr. Yehia Daaka and Dr. Jong Park
presented Tools for Molecular Basis. The last pre-confer-
ence workshop was on Research Collaboration with Low
Resource Countries: Overcoming the Challenges, and was
presented by Dr. Akinremi (chair) and Dr. Folakemi
Odedina.
The Opening Plenary Session took place on Saturday,
August 28 with opening remarks by Dr. Folakemi Odedina
(Conference Chair) and program overview provided by
Mr. Virgil Simons. The conference was officially opened
by Senator Anthony Hill Sr (Minority Whip, FL).
Dr. Vickie L.. Shavers (National Cancer Institute) and Col.
Robert E. Porter (100 Black men Jacksonville) welcomed
all conference delegates, and Dr. Paul Okunieff (UF
Shands Cancer Center Director) gave the Welcome
Address. The key note speaker was introduced by Dr. Rick
Kittles (Scientific Program Committee Co-Chair).
A Community-Academic Town Hall Forum was held
on Saturday, August 28 on PSA Testing in Black Men
Across the Globe: Policy Implications. This session
was moderated by Dr. Charles Rosser and Mr. Anthony
Grissett. The speakers/panelists were Dr. Frank Chineg-
wundoh ( UK), Dr. Femi Ogunbiyi (Nigeria), Dr. Robin
Roberts (Bahamas) and Dr. Curtis Pettaway (USA).
Keynote speaker
The key note speaker was Dr. John Carpten, PhD.
Dr. Carpten is Professor and Director of Integrated Cancer
Genomics Division, and Head of the Cancer Gene Discov-
ery and Molecular Validation Unit at the Translational
Genomics Research Institute. Dr. Carpten delivered an
outstanding lecture on the status of the African American
Hereditary Prostate Cancer Study Network. This multi-
center collaboration has recruited a large number of
African American families with men who have a high risk
of developing prostate cancer to identify the genetic risk
factors for prostate cancer.
Bio-ecological system approach to understanding
prostate cancer disparities
Nationally and internationally renowned experts were
invited to present the latest findings on prostate cancer
research for the conference plenary sessions. The first
plenary session focused on Epidemiology and Genetics
and was led by Dr. Rick Kittles who presented along with
Dr. Tim Rebbeck. Mr. Theodies Mitchell, Jr. chaired
plenary session two, with Dr. Alexander Asea,
Dr. Richard Ablin, and Dr. Philipp Dahm presenting on
Prevention and treatment.
Psychosocial and Behavioral Factors was the focus
of plenary session three which was chaired by Dr. Carole
Kimberlin, and included presentations from Dr. Fola-
kemi Odedina, as well as Dr. V. Diane Woods. Dr. Rich
Segal chaired plenary session four with presentations
from Dr. Isaac Powell and Dr. Camille Ragin which
focused on Geographical and Outcome Variations.
Dr. Vickie L. Shavers chaired plenary session five with
Dr. Rick Kittles, Dr. Femi Ogunbiyi (Nigeria), and
Dr. Robin Roberts (Bahamas) presenting on The Transla-
tion Continuum: Innovative Research Approaches to
Addressing Prostate Cancer Disparities from Bench to
Bedside to Community. Plenary session six focused on
Funding Opportunities for Prostate Cancer Disparities.
The session was chaired by Dr. Frank Chinegwundoh
(UK) with presentations by Dr. Alexis Bakos (National
Cancer Institute), Dr. Carolyn Best (Department of
Defense), and Dr. Ronilt Elk (American Cancer Society).
The final plenary session was From Community to
Bench: Researchable Community Issues on Prostate
Cancer by Mr. Jim West (chair) and Dr. Willie Kimmons.
Abstract presentations: podium and poster
presentations
A total of 13 abstract submissions were accepted for pre-
sentation at the conference. Four posters were presented
during a 3-hour poster session on Saturday afternoon. The
poster abstracts were placed in either of two categories,
Prevention & Early Detection or Prostate Cancer – Pro-
tective and Risk factors. Dr. Richard Segal and Dr. Robin
Roberts (Bahamas) moderated the poster sessions. The
posters presentations were Histopathological Review of
Prostate Cancer in Lokoja, Nigeria by Dr. Olabode Olu-
wole; The Role of Dietary Fat in Prostate Cancer Risk in
Jamaican Men: A Pilot Study by Dr. Ayokunle Osho;
Correlation Between Gleason Grade And Age At Presenta-
tion Of Prostate Cancer in Black Men in Abeokuta, Nigeria
by Dr. A. Olutunde; and Prostate Cancer: Histopathologi-
cal Analysis of 66 cases by Dr. Olabode Oluwole
There were nine oral podium presentations. Dr. B. Lee
Green was the moderator for the first oral presentation
session. The presenters were Dr. M. Tokunboh Odubanjo
(Nigeria) who presented on the Prognostic Factors for
Prostatic Carcinoma Among Men in Lagos, Nigeria;
Dr. V. Diane Woods who discussed African American
Men’s Response to Prostate Cancer Prevention and Early
Detection: The Pcap Toolkit;a n dD r .K a b o r eA r i s t i d e
(Burkina Faso) who gave a presentation on Prostate
Cancer Outcome in Burkina Faso.
The second oral presentation session was led by
Dr. R. Renee Reams, who also gave an overview of
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African American. During the same session, Ms. Jenni-
fer Green presented a study on The Efficacy and Toxi-
city of Selective Estrogen Receptor Modulators in the
LNCaP Cell Line; Dr. Rose Mary Stiffin provided an
overview on The Presence of Megakaryocytes in Cancer-
ous Prostate Cancer Tissue;a n dD r .H e r n a nF l o r e s -
Rozas discussed the Differential Contribution of Mis-
match Repair Genes in the Processing of DNA Damage.
Dr. Jong Park moderated the third oral presentation
session, in which Dr. Titilola Akinremi (Nigeria) gave a
presentation on the Review of Prostate Cancer Research
in Nigeria and Dr. Belinda Morrison (Jamaica) gave an
overview of her work on Bone Mineral Density in
Jamaican Men on Androgen Deprivation Therapy for
Prostate Cancer.
The prostate cancer patient and provider
symposium
The patient and provider symposium was organized by the
Prostate Net and chaired by Mr. Virgil Simons, Founder
and President of Prostate Net. This symposium was a
unique experience allowing patients to learn with and
learn from prostate cancer providers and researchers.
Patient/Survivor Track. The Patient/Survivor track was
moderated by Dr. Brian Stone. He gave a presentation on
the Prevention and Diagnosis of Prostate Cancer.
Following Dr. Stone’s presentation , a joint session on
Prostate Cancer Treatment: What’sB e s tf o rY o uwas
led by Dr. Winston Tan, Dr. Stephen Ko, and Dr. David
Theil. Dr. Paul Godley presented next on Efficacy of
PSA Screening for Prostate Cancer among Elderly
African Americans: A Case-Control Study.
The Keynote Luncheon was given by Dr. Oliver Sartor
who discussed the Emerging Trends, Issues & Treatment
in Late-Stage Disease. For the afternoon session,
Dr. Brian Stone and Dr. Elisabeth Heath discussed the
Treatment of Advanced Stage Disease followed by a pre-
sentation on Controlling Therapeutic Side Effects/Pain
Management and by Dr. Stephen Ko and Dr. David Theil.
Provider Track. The provider track targeted clinicians
and offered CME provided by the University of Florida.
Dr. Stephen Ko and Dr. David Theil opened this track
with a presentation on Managing Hormone Sensitive,
Non-Metastatic Relapse Prostate Cancer.T h en e x t
presentation was Managing Castrate-Resistant, Meta-
static Prostate Cancer by Dr. Winston Tan (chair) and
Dr. Elisabeth Heath.
The Prostate Cancer Patient and Provider Symposium
concluded with a Joint Provider-Patient Symposium ses-
sion discussing the Future of Prostate Cancer Research
and How to Address Clinical Trial Barriers. This session
was moderated by Dr. Elisabeth Heath and Mr. Virgil
Simons
Special sessions
To foster dialogue between patients and leading prostate
cancer clinicians, a Meet the Clinical Experts session was
held on Saturday, August 28 presided by Dr. Christopher
Williams. Six breakfast round table discussions were held
on diverse prostate cancer topics led by Dr. Christopher
Williams, Dr. Durado Brooks, Dr. Chidiebere Ogo
(Nigeria), Dr. Adeteru Ayoade (Nigeria), Dr. Curtis Pett-
away, and Dr. Charles Rosser.
Future plans
Global collaborations are essential to better understand
and effectively address the disproportionate burden of
prostate cancer seen in Black men. To foster global colla-
borations and accelerate prostate cancer control and cure,
the “Science of Global Prostate Cancer Disparities in
Black Men” will be held biennially. The next conference
will be in The Bahamas and will focus on the “Global
Burden of Prostate Cancer: Economic, Clinical and Huma-
nistic Outcomes of Prevention, Detection & Treatment”.
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